Viewing Study NCT01149356


Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2026-01-03 @ 8:17 PM
Study NCT ID: NCT01149356
Status: TERMINATED
Last Update Posted: 2015-05-25
First Post: 2010-06-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: RO4929097 And Exemestane in Treating Pre- and Postmenopausal Patients With Advanced or Metastatic Breast Cancer
Sponsor: National Cancer Institute (NCI)
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Estrogen Receptor Positive View
None HER2/Neu Negative View
None Male Breast Carcinoma View
None Recurrent Breast Carcinoma View
None Stage IIIB Breast Cancer View
None Stage IIIC Breast Cancer View
None Stage IV Breast Cancer View
Keywords: